TickerFacts.

Biotricity Inc. (BTCY): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$719.0K
Year ended 2026-03-31
$161.7K
Trailing 12 months to 2026-06-30
2014-08-31: -$8.2K2015-12-31: -$1.96M2017-03-31: -$3.75M2018-03-31: -$4.87M2019-03-31: -$5.22M2020-03-31: -$7.86M2021-03-31: -$11.08M2022-03-31: -$15.16M2023-03-31: -$13.55M2024-03-31: -$6.69M2025-03-31: -$2.38M2026-03-31: -$719.0K-$719.0K
2014-08-31 Operating Cash Flow (USD) 2026-03-31
Period endedOperating Cash FlowChange YoYSource filing
2026-03-31-$719.0Kn/m2026-07-14, From 2025-04-01
2025-03-31-$2.38Mn/m2026-07-14, From 2024-04-01
2024-03-31-$6.69Mn/m2025-07-18, From 2023-04-01
2023-03-31-$13.55Mn/m2024-06-27, From 2022-04-01
2022-03-31-$15.16Mn/m2023-06-29, From 2021-04-01
2021-03-31-$11.08Mn/m2022-07-14, From 2020-04-01
2020-03-31-$7.86Mn/m2021-06-22, From 2019-04-01
2019-03-31-$5.22Mn/m2020-07-15, From 2018-04-01
2018-03-31-$4.87Mn/m2019-07-16, From 2017-04-01
2017-03-31-$3.75Mn/a2018-07-13, From 2016-04-01
No annual figure between 2015-12-31 and 2017-03-31.
2015-12-31-$1.96Mn/a2017-03-30, From 2015-01-01
No annual figure between 2014-08-31 and 2015-12-31.
2014-08-31-$8.2Kn/a2015-11-30, From 2013-09-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Biotricity Inc. (BTCY)2026-03-31-$719.0Kn/m
Profound Medical Corp. (PROF)2025-12-31-$38.21Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$28.95Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$15.26Mn/m
Nephros Inc (NEPH)2025-12-31$1.60Mn/m
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31-$3.93Mn/m
Spectral AI, Inc. (MDAI)2025-12-31-$9.92Mn/m
DarioHealth Corp. (DRIO)2025-12-31-$25.94Mn/m
Nexgel, Inc. (NXGL)2025-12-31-$1.31Mn/m

Compare BTCY, PROF, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗